A detailed history of New York State Common Retirement Fund transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 43,422 shares of XERS stock, worth $314,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,422
Previous 43,422 -0.0%
Holding current value
$314,809
Previous $202,000 73.76%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Oct 08, 2025

BUY
$3.2 - $5.95 $65,920 - $122,570
20,600 Added 90.26%
43,422 $238,000
Q1 2025

May 01, 2025

BUY
$3.2 - $5.95 $65,920 - $122,570
20,600 Added 90.26%
43,422 $238,000
Q3 2024

Oct 08, 2025

SELL
$2.06 - $2.96 $42,436 - $60,976
-20,600 Reduced 47.44%
22,822 $65,000
Q2 2024

Oct 08, 2025

SELL
$1.7 - $2.45 $35,020 - $50,470
-20,600 Reduced 47.44%
22,822 $51,000
Q2 2024

Jul 31, 2024

BUY
$1.7 - $2.45 $64 - $93
38 Added 0.17%
22,822 $51,000
Q1 2024

Oct 08, 2025

SELL
$2.04 - $3.22 $42,101 - $66,454
-20,638 Reduced 47.53%
22,784 $50,000
Q1 2024

May 07, 2024

SELL
$2.04 - $3.22 $185 - $293
-91 Reduced 0.4%
22,784 $50,000
Q4 2023

Oct 08, 2025

SELL
$1.47 - $2.36 $30,204 - $48,490
-20,547 Reduced 47.32%
22,875 $53,000
Q4 2023

Feb 01, 2024

SELL
$1.47 - $2.36 $382 - $613
-260 Reduced 1.12%
22,875 $54,000
Q3 2023

Oct 08, 2025

SELL
$1.8 - $2.69 $36,516 - $54,572
-20,287 Reduced 46.72%
23,135 $43,000
Q3 2023

Nov 07, 2023

BUY
$1.8 - $2.69 $833 - $1,245
463 Added 2.04%
23,135 $43,000
Q2 2023

Oct 08, 2025

SELL
$1.82 - $2.98 $37,765 - $61,835
-20,750 Reduced 47.79%
22,672 $59,000
Q2 2023

Aug 07, 2023

SELL
$1.82 - $2.98 $209 - $342
-115 Reduced 0.5%
22,672 $59,000
Q1 2023

Oct 08, 2025

SELL
$1.03 - $1.63 $71,791 - $113,610
-69,700 Reduced 75.36%
22,787 $37,000
Q1 2023

May 02, 2023

SELL
$1.03 - $1.63 $71,791 - $113,610
-69,700 Reduced 75.36%
22,787 $37,000
Q4 2022

Oct 08, 2025

BUY
$1.14 - $1.65 $55,934 - $80,957
49,065 Added 113.0%
92,487 $123,000
Q4 2022

Jan 30, 2023

SELL
$1.14 - $1.65 $14 - $21
-13 Reduced 0.01%
92,487 $123,000
Q3 2022

Nov 08, 2022

BUY
$1.37 - $1.93 $1,507 - $2,123
1,100 Added 1.2%
92,500 $144,000
Q2 2022

Aug 04, 2022

BUY
$1.48 - $2.64 $135,272 - $241,296
91,400 New
91,400 $141,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $986M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.